Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01004523 · ClinicalTrials.gov registry record
Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 135
- Enrollment target
NCT01004523 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 135 participants.
The verdict
NCT01004523 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 135 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue and blood samples from patients with low-grade glioma.
Interventions
- GENETIC polymerase chain reaction
- OTHER immunohistochemistry staining method
- OTHER flow cytometry
- GENETIC fluorescence in situ hybridization
- GENETIC loss of heterozygosity analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 1995-12 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01004523
The ClinicalTrials.gov registry entry for NCT01004523 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which polymerase chain reaction is the first listed.
NCT01004523 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01004523 about?
NCT01004523 is a clinical study titled "Study of Tissue and Blood Samples From Patients With Low-Grade Glioma". RATIONALE: Studying samples of tumor tissue and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research st...
What is the current status of trial NCT01004523?
This trial is currently completed. The enrollment target is 135 participants. The study started on 1995-12. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01004523?
The interventions under investigation include: polymerase chain reaction (GENETIC), immunohistochemistry staining method (OTHER), flow cytometry (OTHER), fluorescence in situ hybridization (GENETIC), loss of heterozygosity analysis (GENETIC).
Who is sponsoring clinical trial NCT01004523?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.